Affiliation
Department of Endocrinology , King's College Hospital LondonIssue Date
2015
Metadata
Show full item recordAbstract
The management of hyponatremia has evolved in recent years, particularly with the introduction of tolvaptan for hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). This commentary presents a summary of recent international recommendations in the form of a series of didactic 'dos and don'ts', in order to provide concise, practical guidance for practising clinicians focused on the investigation and management of euvolemic hyponatremia (SIADH).Citation
'Dos and don'ts' in the management of hyponatremia. 2015, 31 (9):1755-61 Curr Med Res OpinJournal
Current Medical Research and OpinionDOI
10.1185/03007995.2015.1072706PubMed ID
26173050Type
ArticleLanguage
enISSN
1473-4877ae974a485f413a2113503eed53cd6c53
10.1185/03007995.2015.1072706